1. CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma. Issue 2 (10th August 2016) Authors: Betti, M.; Aspesi, A.; Biasi, A.; Casalone, E.; Ferrante, D.; Ogliara, P.; Gironi, L.C.; Giorgione, R.; Farinelli, P.; Grosso, F.; Libener, R.; Rosato, S.; Turchetti, D.; Maffè, A.; Casadio, C.; Ascoli, V.; Dianzani, C.; Colombo, E.; Piccolini, E.; Pavesi, M. Journal: Cancer letters Issue: Volume 378:Issue 2(2016) Page Start: 120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comment on `The detection rate of human papillomavirus in well‐differentiated squamous cell carcinoma and keratoacanthoma: is there new evidence for a viral pathogenesis of keratoacanthoma?' ‐ reply from authors. (15th October 2019) Authors: Conforti, C.; Paolini, F.; Venuti, A.; Dianzani, C.; Zalaudek, I. Journal: British journal of dermatology Issue: Volume 181:Number 6(2019) Page Start: 1345 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Comment on `The detection rate of human papillomavirus in well‐differentiated squamous cell carcinoma and keratoacanthoma: is there new evidence for a viral pathogenesis of keratoacanthoma?' ‐ reply from authors. (1st December 2019) Authors: Conforti, C.; Paolini, F.; Venuti, A.; Dianzani, C.; Zalaudek, I. Journal: British journal of dermatology Issue: Volume 181:Number 6(2019) Page Start: 1345 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cyclic nigerosyl-1, 6-nigerose-based nanosponges: An innovative pH and time-controlled nanocarrier for improving cancer treatment. (15th August 2018) Authors: Caldera, F.; Argenziano, M.; Trotta, F.; Dianzani, C.; Gigliotti, L.; Tannous, M.; Pastero, L.; Aquilano, D.; Nishimoto, T.; Higashiyama, T.; Cavalli, R. Journal: Carbohydrate polymers Issue: Volume 194(2018) Page Start: 111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Dupilumab ocular side effects in patients with atopic dermatitis: a systematic review. (17th February 2022) Authors: Neagu, N.; Dianzani, C.; Avallone, G.; Dell'Aquila, C.; Morariu, S.‐H.; Zalaudek, I.; Conforti, C. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 6(2022) Page Start: 820 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Solid Lipid Nanoparticles as New System for the Delivery of Temozolomide in a Mouse Model of Melanoma. Issue 1 (January 2018) Authors: Biasibetti, E.; Battaglia, L.; Veglio, R.; Ferrara, B.; Muntoni, E.; Cangemi, L.; Evangelista, R.; Capucchio, M.T.; Dianzani, C. Journal: Journal of comparative pathology Issue: Volume 158:Issue 1(2018) Page Start: 110 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The detection rate of human papillomavirus in well‐differentiated squamous cell carcinoma and keratoacanthoma: is there new evidence for a viral pathogenesis of keratoacanthoma?. (13th August 2019) Authors: Conforti, C.; Paolini, F.; Venuti, A.; Dianzani, C.; Zalaudek, I. Journal: British journal of dermatology Issue: Volume 181:Number 6(2019) Page Start: 1309 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The detection rate of human papillomavirus in well‐differentiated squamous cell carcinoma and keratoacanthoma: is there new evidence for a viral pathogenesis of keratoacanthoma?. (1st December 2019) Authors: Conforti, C.; Paolini, F.; Venuti, A.; Dianzani, C.; Zalaudek, I. Journal: British journal of dermatology Issue: Volume 181:Number 6(2019) Page Start: 1309 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗